Abstract
Wild-type LRA-5, recovered from Alaskan soil samples, shares no more than 33% amino acid sequence identity with enzymes from pathogens like PER β-lactamases. Recombinant E. coli expressing wild-type LRA-5 and its engineered variants LRA-5Y69Q and LRA-5V166E showed MIC values equivalent to control strains. However, LRA-5Y69Q/V166E displayed MICs above the resistant breakpoint for some β-lactams. Kinetic parameters correlated with the MICs, showing that the catalytic efficiency of LRA-5Y69Q/V166E was comparable to those from class A β-lactamases, such as CTX-M-15, PER-2, and KPC-2. LRA-5Y69Q/V166E exhibited kcat/Km values up to 11,000-fold higher compared to wild-type LRA-5, which is associated with the presence of Glu166. The X-ray crystallographic structure of wild-type LRA-5 (1.80 Å; PDB 8EO5) shows that the lack of both Glu166 and a deacylation water molecule contributes to a biologically insignificant activity. Interactions observed between LRA-5 and ceftazidime (2.35 Å; PDB 8EO6) show structural conservation with other β-lactamases. In contrast, the crystallographic structure of LRA-5Y69Q/V166E (2.15 Å; PDB 8EO7) bears a deacylation water molecule that is associated with the increase in catalytic activity compared to the wild-type variant. Circular dichroism results confirm that amino acid substitutions in LRA-5 do not affect the overall content of the secondary/tertiary structures. Evidence suggests that alternative evolutionary paths could have occurred for β-lactamases like LRA-5, produced by environmental microorganisms: (i) proteins having similar structural features than active β-lactamases may accumulate a small number of mutations (e.g., Y69Q/V166E) to yield active enzymes and (ii) the β-lactamase fold may have lost key residues in the absence of antibiotics.
| Original language | English |
|---|---|
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | 70 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2026 |
Bibliographical note
Publisher Copyright:Copyright © 2025 D'Amico González et al.
Funding
We acknowledge access to the Proxima-2A beamline at the SOLEIL Synchrotron, France (Proposal No. 20181069). We are also grateful to the Center for Structural Biology of the Mercosur (CEBEM), CCP4 and the Diamond Light Source, UK, for their access to the I03 beamline during the 2021 online course “Structural Biology to enhance high impact research in health and disease.” We thank Dr. Jo Handelsman for her invaluable support and for providing the original constructions expressing the LRA enzymes. We thank Dr. Lucrecia Curto (IQUIFIB, CONICET) for assisting us with the circular dichroism experiment. This work was supported, in part, by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI160371 to P. Power (PI) and R. Powers (co-PI). Also, the work was partially funded by grants from Agencia Nacional de Promoción Científica y Tecnológica (PICT-2021-I-A-0771), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET, PIP 2021-2023 11220200100191CO), and Universidad de Buenos Aires (UBACYT 2018 and 2023) to P. Power. This work was supported, in part, by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI160371 to P. Power (PI) and R. Powers (co-PI). Also, the work was partially funded by grants from Agencia Nacional de Promoción Científica y Tecnológica (PICT-2021-I-A-0771), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET, PIP 2021-2023 11220200100191CO), and Universidad de Buenos Aires (UBACYT 2018 and 2023) to P. Power. We dedicate this work to the loving memory of Heather K. Allen (R.I.P.).
| Funders | Funder number |
|---|---|
| Center for Structural Biology of the Mercosur | |
| Universidad de Buenos Aires | |
| National Institute of Allergy and Infectious F32-AI286447 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI168214 Jason W. Rosch Diseases National Institute of Allergy and Infectious P30 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R00-AI166116 Christopher D. Radka Diseases National Institute of Allergy and Infectious T32-AI106700 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI192221 Jason W. Rosch Diseases National Inst... | |
| Agencia Nacional de Promoción Científica y Tecnológica | PICT-2021-I-A-0771 |
| Secretaría de Ciencia y Técnica, Universidad de Buenos Aires | 2018, 2023 |
| Consejo Nacional de Investigaciones Científicas y Técnicas | PIP 2021-2023 11220200100191CO |
| National Institutes of Health (NIH) | R01AI160371 |
Keywords
- Alaskan soil metagenome
- X-ray crystallography
- ceftazidime
- β-lactamase evolution
- β-lactamase precursor
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases